Jian-hong M. Zhong
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 227 publications
Associations of body weight perceptions with suicidal ideation and suicidal attempts among middle and high school students in Zhejiang Province
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: August 19, 2026
Preoperative gut microbiota combined with machine learning for predicting post-hepatectomy liver failure in HBV-related hepatocellular carcinoma: a pilot study.
Journal: Frontiers in cellular and infection microbiology
Published: May 10, 2026
Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008).
Journal: Scientific reports
Published: April 16, 2026
Reply to the Comment on the Article "Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor Based Combination Therapy for Unresectable Hepatocellular Carcinoma".
Journal: Liver cancer
Published: April 07, 2026
Reply to "Methodological Concerns in 'Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma'".
Journal: Liver cancer
Published: March 26, 2026
Adjuvant immunotherapy for hepatocellular carcinoma: Precision selection of the optimal target population as the core strategy.
Journal: Journal of hepatology
Published: February 02, 2026
Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection.
Journal: Alimentary pharmacology & therapeutics
Published: January 25, 2026
Advancing hepatology through innovation and integration: iLIVER's vision for 2026.
Journal: iLIVER
Published: January 11, 2026
Study design and characteristics of participants in baseline investigation Zhejiang Childhood Behavior and Health Cohort
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: December 22, 2025
Multimodal therapeutic efficacy model for predicting early treatment response to TACE-HAIC combined with immune checkpoint inhibitors and tyrosine kinase inhibitors in unresectable hepatocellular carcinoma.
Journal: European journal of radiology
Published: November 30, 2025
Efficacy and safety of adjuvant transarterial chemoembolization in high-risk HCC after curative hepatectomy: a phase III RCT protocol.
Journal: iLIVER
Published: November 27, 2025
Last Updated: 09/26/2026